209 related articles for article (PubMed ID: 30257000)
1. Olfactory Ensheathing Cells: A Trojan Horse for Glioma Gene Therapy.
Carvalho LA; Teng J; Fleming RL; Tabet EI; Zinter M; de Melo Reis RA; Tannous BA
J Natl Cancer Inst; 2019 Mar; 111(3):283-291. PubMed ID: 30257000
[TBL] [Abstract][Full Text] [Related]
2. Improvement of antitumor activity by gene amplification with a replicating but nondisseminating adenovirus.
Bourbeau D; Lau CJ; Jaime J; Koty Z; Zehntner SP; Lavoie G; Mes-Masson AM; Nalbantoglu J; Massie B
Cancer Res; 2007 Apr; 67(7):3387-95. PubMed ID: 17409449
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study.
Lv SQ; Zhang KB; Zhang EE; Gao FY; Yin CL; Huang CJ; He JQ; Yang H
Med Sci Monit; 2009 Jan; 15(1):BR13-20. PubMed ID: 19114960
[TBL] [Abstract][Full Text] [Related]
4. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
5. Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice.
Khatri A; Zhang B; Doherty E; Chapman J; Ow K; Pwint H; Martiniello-Wilks R; Russell PJ
J Gene Med; 2006 Sep; 8(9):1086-96. PubMed ID: 16832832
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties.
Yi BR; Kim SU; Kim YB; Lee HJ; Cho MH; Choi KC
Oncol Rep; 2012 Jun; 27(6):1823-8. PubMed ID: 22426744
[TBL] [Abstract][Full Text] [Related]
7. Lamina propria and olfactory bulb ensheathing cells exhibit differential integration and migration and promote differential axon sprouting in the lesioned spinal cord.
Richter MW; Fletcher PA; Liu J; Tetzlaff W; Roskams AJ
J Neurosci; 2005 Nov; 25(46):10700-11. PubMed ID: 16291943
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma.
Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY
Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135
[TBL] [Abstract][Full Text] [Related]
9. Vectorized gene therapy of liver tumors: proof-of-concept of TG4023 (MVA-FCU1) in combination with flucytosine.
Husseini F; Delord JP; Fournel-Federico C; Guitton J; Erbs P; Homerin M; Halluard C; Jemming C; Orange C; Limacher JM; Kurtz JE
Ann Oncol; 2017 Jan; 28(1):169-174. PubMed ID: 28177438
[TBL] [Abstract][Full Text] [Related]
10. A New Approach in Gene Therapy of Glioblastoma Multiforme: Human Olfactory Ensheathing Cells as a Novel Carrier for Suicide Gene Delivery.
Hashemi M; Fallah A; Aghayan HR; Arjmand B; Yazdani N; Verdi J; Ghodsi SM; Miri SM; Hadjighassem M
Mol Neurobiol; 2016 Oct; 53(8):5118-28. PubMed ID: 26395282
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector.
Takahashi M; Valdes G; Hiraoka K; Inagaki A; Kamijima S; Micewicz E; Gruber HE; Robbins JM; Jolly DJ; McBride WH; Iwamoto KS; Kasahara N
Cancer Gene Ther; 2014 Oct; 21(10):405-410. PubMed ID: 25301172
[TBL] [Abstract][Full Text] [Related]
12. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
13. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
[TBL] [Abstract][Full Text] [Related]
14. The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase.
Chang DY; Yoo SW; Hong Y; Kim S; Kim SJ; Yoon SH; Cho KG; Paek SH; Lee YD; Kim SS; Suh-Kim H
Int J Cancer; 2010 Oct; 127(8):1975-83. PubMed ID: 20473873
[TBL] [Abstract][Full Text] [Related]
15. Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.
Aboody KS; Najbauer J; Metz MZ; D'Apuzzo M; Gutova M; Annala AJ; Synold TW; Couture LA; Blanchard S; Moats RA; Garcia E; Aramburo S; Valenzuela VV; Frank RT; Barish ME; Brown CE; Kim SU; Badie B; Portnow J
Sci Transl Med; 2013 May; 5(184):184ra59. PubMed ID: 23658244
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
[TBL] [Abstract][Full Text] [Related]
17. The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies.
Hamstra DA; Lee KC; Tychewicz JM; Schepkin VD; Moffat BA; Chen M; Dornfeld KJ; Lawrence TS; Chenevert TL; Ross BD; Gelovani JT; Rehemtulla A
Mol Ther; 2004 Nov; 10(5):916-28. PubMed ID: 15509509
[TBL] [Abstract][Full Text] [Related]
18. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
19. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
[TBL] [Abstract][Full Text] [Related]
20. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
Porosnicu M; Mian A; Barber GN
Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
